Raskob G E, Angchaisuksiri P, Blanco A N, Buller H, Gallus A, Hunt B J, Hylek E M, Kakkar A, Konstantinides S V, McCumber M, Ozaki Y, Wendelboe A, Weitz J I
From the College of Public Health, University of Oklahoma Health Sciences Center (G.E.R., M.M., A.W.); Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (P.A.); División Hemostasia, Academia Nacional de Medicina, Buenos Aires, Argentina (A.N.B.); Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands (H.B.); SA Pathology-Department of Hematology, Flinders Medical Center, Adelaide, South Australia, Australia (A.G.); Thrombosis and Thrombophilia Centre, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom (B.J.H.); Boston University School of Medicine, MA (E.M.H.); Thrombosis Research Institute, London, United Kingdom (A.K.); Center for Thrombosis and Hemostasis, Johannes Gutenberg University, Mainz, Germany (S.V.K.); Department of Laboratory Medicine, University of Yamanashi, Tamaho, Yamanashi, Japan (Y.O.); and McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada (J.I.W.).
Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2363-71. doi: 10.1161/ATVBAHA.114.304488.
Thrombosis is the common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused 1 in 4 deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability.
To review the literature on the global burden of disease caused by VTE.
We performed a systematic review of the literature on the global disease burden because of VTE in low-, middle-, and high-income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded consistent results with annual incidences ranging from 0.75 to 2.69 per 1000 individuals in the population. The incidence increased to between 2 and 7 per 1000 among those aged ≥70 years. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low because of population aging. VTE associated with hospitalization was the leading cause of disability-adjusted life-years lost in low- and middle-income countries, and second in high-income countries, responsible for more disability-adjusted life-years lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events.
VTE causes a major burden of disease across low-, middle-, and high-income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems and to evaluate whether improved use of preventive measures will reduce the burden.
血栓形成是缺血性心脏病、缺血性中风和静脉血栓栓塞症(VTE)的共同病理基础。《2010年全球疾病负担研究》(GBD 2010)记录显示,缺血性心脏病和中风共同导致了全球四分之一的死亡。GBD 2010未报告VTE作为死亡和残疾原因的数据。
回顾关于VTE所致全球疾病负担的文献。
我们对低收入、中等收入和高收入国家中因VTE所致全球疾病负担的文献进行了系统综述。来自西欧、北美、澳大利亚和拉丁美洲南部(阿根廷)的研究得出了一致的结果,人群年发病率在每1000人0.75至2.69之间。在70岁及以上人群中,发病率增至每1000人2至7之间。尽管华裔和韩裔个体的发病率较低,但由于人口老龄化,他们的疾病负担并不低。在低收入和中等收入国家,与住院相关的VTE是导致伤残调整生命年损失的主要原因,在高收入国家中位列第二,造成的伤残调整生命年损失超过医院获得性肺炎、导管相关血流感染和药物不良事件。
VTE在低收入、中等收入和高收入国家均造成了重大疾病负担。应获取关于VTE全球负担的更详细数据,以为卫生系统的政策制定和资源分配提供依据,并评估加强预防措施的使用是否会减轻负担。